← Back to guidelines
Cardiology1 paper

Congenital hypertrophy of pylorus

Last edited: 4/23/2026

Overview

Congenital hypertrophy of the pylorus (CHH) is a rare congenital anomaly characterized by abnormal thickening and hypertrophy of the pyloric muscle, leading to gastric outlet obstruction 1. This condition primarily affects neonates and infants, causing symptoms such as vomiting, feeding difficulties, and failure to thrive 1.

Diagnosis

  • Clinical presentation includes projectile vomiting, dehydration, and weight loss in infants 1.
  • Imaging studies such as ultrasound, upper GI series, and sometimes MRI are crucial for diagnosis, revealing pyloric thickening and potential gastric dilation 1.
  • Endoscopy may be used to assess the degree of obstruction and rule out other causes of gastric outlet obstruction 1.
  • Management

  • Initial management often involves conservative measures like nasogastric tube decompression and intravenous hydration to stabilize the infant 1.
  • Surgical intervention, typically a pyloromyotomy, is the definitive treatment to relieve obstruction and promote normal gastric emptying 1.
  • Postoperatively, close monitoring for complications such as anastomotic leaks or recurrent obstruction is essential 1.
  • Special Populations

  • No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.
  • Key Recommendations

  • Perform imaging studies (ultrasound, upper GI series) for definitive diagnosis of congenital hypertrophy of the pylorus 1.
  • Initiate conservative management with nasogastric tube decompression and intravenous fluids before surgical intervention 1.
  • Consider pyloromyotomy as the primary surgical approach to resolve gastric outlet obstruction 1.
  • (Evidence: Expert opinion)

    References

    1 McCullough CJ, Kenwright J. The prognosis in congenital lower limb hypertrophy. Acta orthopaedica Scandinavica 1979. link

    Original source

    1. [1]
      The prognosis in congenital lower limb hypertrophy.McCullough CJ, Kenwright J Acta orthopaedica Scandinavica (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG